Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2019

01-12-2019 | Insulins | Research article

Appropriateness of insulin commencement and adequacy of glycemic control among ambulatory patients with type 2 diabetes in Ethiopia

Authors: Adane Teshome Kefale, Tessema Tsehay Biru, Habtamu Acho Addo

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2019

Login to get access

Abstract

Background

Knowing when to start insulin is central to optimal management of Type 2 diabetes mellitus (T2DM) but a real clinical challenge. Poor glycemic control is critical for development of the deadly diabetic complications.

Objective

The aim of the study was to assess the appropriateness of insulin commencement, adequacy of glycemic control and associated factors among patients with T2DM.

Settings

The study was conducted at three public hospitals in Southwest Ethiopia.

Methods

Cross sectional study was conducted using structured questionnaire and data abstraction format. All patients with T2DM who were available during the data collection period and fulfilling study criteria were included.

Main outcome measure

Multivariable binary logistic regression analysis was done for identifying factors associated with poor glycemic control by taking statistical significance at p value ≤0.05.

Results

One hundred sixty nine patient data was considered for analysis. Insulin was initiated in 28 patients, but only 10(35.7%) insulin commencements were appropriate. More than two third (70.4%) of the studied population had poor glycemic control. Addition of second antidiabetic medication (Adjusted Odds Ratio (AOR) = 2.5, 95% CI = 1.3–6.2) and living in urban areas (AOR = 2.5, 95% CI = 1.1–5.7) were associated with poor glycemic control while having regular diabetic care follow up of every >1 month (AOR = 0.4, 95% CI = 0.2–0.9) was negatively associated with poor glycemic control.

Conclusions

About two third of insulin commencements were inappropriate and majority of patients could not stay on optimal glycemic control. Addition of second antidiabetic medication and living in urban areas were found to be associated with poor glycemic control.

Impact of findings on practice statements

• Initiation of insulin before optimization of oral agents increase cost of care.
• Proper titration of the first oral agent is important prior to adding other antidiabetic agents.
• Emphasis should be given to improve glycemic control, and hence halt subsequent complications.
Literature
1.
go back to reference World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999.
4.
go back to reference David M, John B, Steven E, Heidik K, Mary E, Myrlene S, et al. Rational and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care. 2013;36:2254–61.CrossRef David M, John B, Steven E, Heidik K, Mary E, Myrlene S, et al. Rational and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care. 2013;36:2254–61.CrossRef
5.
go back to reference UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
7.
go back to reference Wong J. Starting insulin treatment in type 2 diabetes. Aust Prescr. 2004;27(4):93–6.CrossRef Wong J. Starting insulin treatment in type 2 diabetes. Aust Prescr. 2004;27(4):93–6.CrossRef
8.
go back to reference American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2016;39(Suppl 1):S43. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2016;39(Suppl 1):S43.
9.
go back to reference Bhattacharya R, Ajmera M, Sambamoorth U. A real world study of the effect of timing of insulin initiation on outcome in older Medicare beneficiaries with type 2 diabetes mellitus. J Am Geriatr Soc. 2015;63(5):893–901.CrossRef Bhattacharya R, Ajmera M, Sambamoorth U. A real world study of the effect of timing of insulin initiation on outcome in older Medicare beneficiaries with type 2 diabetes mellitus. J Am Geriatr Soc. 2015;63(5):893–901.CrossRef
10.
go back to reference Rubino A, McQuay L, Gought S, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose lowering agents in patients with type 2 diabetes: a population based analysis in the UK. Diabet Med. 2007;24:1412–8.CrossRef Rubino A, McQuay L, Gought S, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose lowering agents in patients with type 2 diabetes: a population based analysis in the UK. Diabet Med. 2007;24:1412–8.CrossRef
11.
go back to reference UK Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK prospective diabetes study (UKPDS 57). Diabetes Care. 2002;25(2):330–6.CrossRef UK Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK prospective diabetes study (UKPDS 57). Diabetes Care. 2002;25(2):330–6.CrossRef
12.
go back to reference David R. Owens. Clinical evidence for earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol Ther. 2013;15(9):776–86.CrossRef David R. Owens. Clinical evidence for earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol Ther. 2013;15(9):776–86.CrossRef
13.
go back to reference Wabe TN, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self-management practices among type2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418–23.CrossRef Wabe TN, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self-management practices among type2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418–23.CrossRef
14.
go back to reference Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria. Pharm Pract. 2011;9(2):72–81. Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria. Pharm Pract. 2011;9(2):72–81.
15.
go back to reference Rwegerera GM. Adherence to antidiabetic drugs among patients with type 2 diabetes mellitus at Muhimbili National Hospital, dares salaam, Tanzania- A cross-sectional study. Pan Afr Med J. 2014;17:252.PubMedPubMedCentral Rwegerera GM. Adherence to antidiabetic drugs among patients with type 2 diabetes mellitus at Muhimbili National Hospital, dares salaam, Tanzania- A cross-sectional study. Pan Afr Med J. 2014;17:252.PubMedPubMedCentral
16.
go back to reference Pascal IG, Ofoedu JN, Uchenna NP, Nkwa AA, Uchamma GE. Blood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of eastern Nigeria. N Am J Med Sci. 2012;4(7):310–5.CrossRef Pascal IG, Ofoedu JN, Uchenna NP, Nkwa AA, Uchamma GE. Blood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of eastern Nigeria. N Am J Med Sci. 2012;4(7):310–5.CrossRef
17.
go back to reference Chua SS, Chan SP. Medication adherence and achievement of glycemic targets in ambulatory type 2 diabetic patients. J App Pharm Sci. 2011;1(4):55–9. Chua SS, Chan SP. Medication adherence and achievement of glycemic targets in ambulatory type 2 diabetic patients. J App Pharm Sci. 2011;1(4):55–9.
18.
go back to reference Gopinath B, Sri Sai Prasad M, Jayarama N, Prabhakara K. Study of factors associated with poor glycemic control in Type −2 Diabetic Patients. Global Journal of Medicine and Public Health. 2013;2(2). Gopinath B, Sri Sai Prasad M, Jayarama N, Prabhakara K. Study of factors associated with poor glycemic control in Type −2 Diabetic Patients. Global Journal of  Medicine and  Public Health. 2013;2(2).
19.
go back to reference Ahmed AT, Karter AJ, Warton EM, Doan JU, Weisner CM. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente northern California diabetes registry. J Gen Intern Med. 2008;23(3):275–82.CrossRef Ahmed AT, Karter AJ, Warton EM, Doan JU, Weisner CM. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente northern California diabetes registry. J Gen Intern Med. 2008;23(3):275–82.CrossRef
20.
go back to reference Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24(2):84–9.CrossRef Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24(2):84–9.CrossRef
21.
go back to reference Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol. 2004;19(6):541–5.CrossRef Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol. 2004;19(6):541–5.CrossRef
22.
go back to reference Chiu CJ, Wray LA. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis. 2010;7(1):A08.PubMed Chiu CJ, Wray LA. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis. 2010;7(1):A08.PubMed
23.
go back to reference Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006–2009. Prev Chronic Dis. 2012;9:120065.CrossRef Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006–2009. Prev Chronic Dis. 2012;9:120065.CrossRef
24.
go back to reference Fiseha T, Alemayehu E, Kassahun W, Adamu A, Gebreweld A. Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia. BMC Res Notes. 2018;11:316.CrossRef Fiseha T, Alemayehu E, Kassahun W, Adamu A, Gebreweld A. Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia. BMC Res Notes. 2018;11:316.CrossRef
25.
go back to reference Kamuhabwa A, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar Es Salaam. Drug Healthc Patient Saf. 2014;6:155–65.CrossRef Kamuhabwa A, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar Es Salaam. Drug Healthc Patient Saf. 2014;6:155–65.CrossRef
26.
go back to reference Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5:36.CrossRef Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5:36.CrossRef
Metadata
Title
Appropriateness of insulin commencement and adequacy of glycemic control among ambulatory patients with type 2 diabetes in Ethiopia
Authors
Adane Teshome Kefale
Tessema Tsehay Biru
Habtamu Acho Addo
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2019
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00448-5

Other articles of this Issue 2/2019

Journal of Diabetes & Metabolic Disorders 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine